Harlan Laboratories expands North American facilities
Several sustainable components have been incorporated in the renovation
Harlan Laboratories, a contract research organisation and supplier of research models and services, has expanded its US production facilities in Indianapolis, Indiana and Livermore, California.
The company said the expansion more than doubles the number of isolators at these sites allowing Harlan to meet growing demand for its immunocompromised models.
Joe Meyer, Vice President Global Commercial Operations at Harlan Laboratories said the investment underscores the company’s commitment to providing the highest quality research models and services.
“We will continue to expand and enhance our facilities worldwide to meet the needs of the research community in key therapeutic research areas like oncology, immunology and toxicology with consistently dependable research models, diets and supporting services,” he said.
The facilities incorporate the latest technology and design. The environmentally controlled breeding isolators are supported by individual air supply and HEPA filtered air handling to ensure the integrity of the colony housed within each isolator. They also feature the latest equipment and biosecurity measures including a watering system with automatic flushing to help prevent the unwanted proliferation of organisms, as well as a whole building redundant backup power system.
Harlan Laboratories has also incorporated several sustainable components to the newly renovated facilities.
“We designed the facilities with a dual purpose – animal care and sustainability. We have incorporated energy efficient lighting and water systems, as well as designed workflows to support our biosecurity practices,” said Mike Lipke, Global Vice President of Operations at Harlan Laboratories.